Rybelsus (semaglutide (oral))
Rybelsus is the only oral GLP-1 medication on the market, offering a daily pill alternative to weekly injections for type 2 diabetes management.
What is Rybelsus and how much does it cost?
Rybelsus (semaglutide (oral)) is a daily oral GLP-1 medication by Novo Nordisk. Average weight loss is 5-8% body weight. Cost without insurance: $900-$1,100/month. With insurance: $25-$100/month.
Rybelsus contains oral semaglutide absorbed through the stomach lining. It works the same as injectable semaglutide but at lower bioavailability, requiring daily dosing.
Mechanism of Action
How Rybelsus Works
Rybelsus contains oral semaglutide absorbed through the stomach lining. It works the same as injectable semaglutide but at lower bioavailability, requiring daily dosing.
Dosing
Rybelsus Dosages
Dosing typically starts at the lowest dose and increases gradually to reduce side effects. Your healthcare provider will determine the appropriate dosing schedule.
Pricing
Rybelsus Cost Breakdown
Novo Nordisk Patient Assistance Program; Rybelsus savings offer
Insurance
Insurance Coverage for Rybelsus
Coverage status across 10 major insurers.
| Insurer | Status | Copay | Denial Rate | Details |
|---|---|---|---|---|
| UnitedHealthcare | prior auth | $25-$50/month | 20-30% | View |
| Anthem / Elevance Health | prior auth | $25-$50/month | 20-30% | View |
| Aetna / CVS Health | prior auth | $25-$50/month | 20-25% | View |
| Cigna | prior auth | $25-$50/month | 20-30% | View |
| Humana | prior auth | $25-$50/month | 15-25% | View |
| Blue Cross Blue Shield (General) | prior auth | $25-$75/month | 20-30% | View |
| Kaiser Permanente | prior auth | $15-$40/month | 15-20% | View |
| Medicare Part D | prior auth | $35-$75/month | 20-25% | View |
| Medicaid (General) | prior auth | $0-$5/month | 25-35% | View |
| TRICARE | prior auth | $0-$25/month | 15-20% | View |
Safety
Rybelsus Side Effects & Warnings
Common Side Effects
- *Nausea
- *Stomach pain
- *Diarrhea
- *Decreased appetite
- *Vomiting
- *Constipation
Serious Warnings
- !Thyroid C-cell tumors (boxed warning)
- !Pancreatitis
- !Hypoglycemia with insulin
- !Kidney problems
- !Allergic reactions
Was Your Rybelsus Denied?
Insurance denials for GLP-1 medications are common but often overturned on appeal. Our Undeniable tool generates AI-powered appeal letters backed by medical evidence.
Research
Active Rybelsus Clinical Trials
Currently recruiting Phase 3 studies for semaglutide (oral). Find trials you may be eligible to join.
Currently Recruiting Clinical Trials
25 active semaglutide studies on ClinicalTrials.gov
Efficacy and Safety of Semaglutide Injection vs WEGOVY in Chinese Obese Patients
NCT07036172
CagriSema Once Weekly for Weight Management in Children and Adolescents With Overweight or Obesity
NCT07253285
Semaglutide for Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
NCT05569772
Clinical Comparability of Two Formulations of Oral Semaglutide in Japanese Participants With Type 2 Diabetes
NCT07271251
Source: ClinicalTrials.gov | As of 2026-03-24
View all trialsFind Rybelsus Trials Near You
Enter your ZIP code to find recruiting clinical trials within 100 miles.
Alternatives
Alternatives to Rybelsus
Compare other GLP-1 medications that may be options for your treatment.
Rybelsus FAQs
How much does Rybelsus cost?
Without insurance, Rybelsus costs approximately $900-$1,100/month. With insurance, copays typically range from $25-$100/month. With coupons or savings programs, costs may be $450-$800/month. Patient assistance: Novo Nordisk Patient Assistance Program; Rybelsus savings offer.
Does insurance cover Rybelsus?
Insurance coverage for Rybelsus varies by plan. Most plans cover it for type 2 diabetes with prior authorization. Coverage for weight loss (off-label) is frequently denied. Check with your specific insurer for details.
What are the side effects of Rybelsus?
Common side effects of Rybelsus include nausea, stomach pain, diarrhea, decreased appetite. These typically improve over time. Serious warnings include thyroid c-cell tumors (boxed warning), pancreatitis, hypoglycemia with insulin. Consult your healthcare provider about risks specific to your situation.
How much weight can I lose on Rybelsus?
Clinical trials show Rybelsus produces an average weight loss of 5-8% body weight. Individual results vary based on starting weight, diet, exercise, dosage, and adherence. Most patients see significant weight loss within 3-6 months at the maintenance dose.
Disclaimer
This information is for educational purposes only and does not constitute medical advice.Rybelsus should only be used under the guidance of a licensed healthcare provider. Individual results, side effects, and insurance coverage vary. Always consult your healthcare provider and insurance company before starting or changing medication.